Lau, J., Bloch, P., Schffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L.B., McGuire, J., Steensgaard, D.B., Strauss, H.M., Gram, D.X., Knudsen, S.M., Nielsen, F.S., Thygesen, P., Reedtz-Runge, S., and Kruse, T., (2015), Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide, Journal of Medicinal Chemistry 58, 7370-7380
Lancet 390(10103):16641675
The more likely reason is telogen effluvium, a temporary shedding that follows rapid weight loss, low protein intake, and nutritional gaps
To compare, Zhongmei stated that preclinical findings have demonstrated that HDM1002 can potently activate the GLP-1 receptor, induce the production of cAMP, and exhibit strong effects in improving glucose tolerance, reducing blood sugar, promoting weight loss, and provide a good safety [profile]